418 related articles for article (PubMed ID: 26304882)
1. Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration.
Dome JS; Graf N; Geller JI; Fernandez CV; Mullen EA; Spreafico F; Van den Heuvel-Eibrink M; Pritchard-Jones K
J Clin Oncol; 2015 Sep; 33(27):2999-3007. PubMed ID: 26304882
[TBL] [Abstract][Full Text] [Related]
2. Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.
Fernandez CV; Mullen EA; Chi YY; Ehrlich PF; Perlman EJ; Kalapurakal JA; Khanna G; Paulino AC; Hamilton TE; Gow KW; Tochner Z; Hoffer FA; Withycombe JS; Shamberger RC; Kim Y; Geller JI; Anderson JR; Grundy PE; Dome JS
J Clin Oncol; 2018 Jan; 36(3):254-261. PubMed ID: 29211618
[TBL] [Abstract][Full Text] [Related]
3. Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape.
Gajjar A; Bowers DC; Karajannis MA; Leary S; Witt H; Gottardo NG
J Clin Oncol; 2015 Sep; 33(27):2986-98. PubMed ID: 26304884
[TBL] [Abstract][Full Text] [Related]
4. Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration.
Pui CH; Yang JJ; Hunger SP; Pieters R; Schrappe M; Biondi A; Vora A; Baruchel A; Silverman LB; Schmiegelow K; Escherich G; Horibe K; Benoit YC; Izraeli S; Yeoh AE; Liang DC; Downing JR; Evans WE; Relling MV; Mullighan CG
J Clin Oncol; 2015 Sep; 33(27):2938-48. PubMed ID: 26304874
[TBL] [Abstract][Full Text] [Related]
5. Risk stratification for wilms tumor: current approach and future directions.
Dome JS; Perlman EJ; Graf N
Am Soc Clin Oncol Educ Book; 2014; ():215-23. PubMed ID: 24857079
[TBL] [Abstract][Full Text] [Related]
6. New approaches to risk stratification for Wilms tumor.
Nelson MV; van den Heuvel-Eibrink MM; Graf N; Dome JS
Curr Opin Pediatr; 2021 Feb; 33(1):40-48. PubMed ID: 33394739
[TBL] [Abstract][Full Text] [Related]
7. Impact of the First Generation of Children's Oncology Group Clinical Trials on Clinical Practice for Wilms Tumor.
Dome JS; Mullen EA; Dix DB; Gratias EJ; Ehrlich PF; Daw NC; Geller JI; Chintagumpala M; Khanna G; Kalapurakal JA; Renfro LA; Perlman EJ; Grundy PE; Fernandez CV
J Natl Compr Canc Netw; 2021 Aug; 19(8):978-985. PubMed ID: 34416705
[TBL] [Abstract][Full Text] [Related]
8. Gain of 1q As a Prognostic Biomarker in Wilms Tumors (WTs) Treated With Preoperative Chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 Trial: A SIOP Renal Tumours Biology Consortium Study.
Chagtai T; Zill C; Dainese L; Wegert J; Savola S; Popov S; Mifsud W; Vujanić G; Sebire N; Le Bouc Y; Ambros PF; Kager L; O'Sullivan MJ; Blaise A; Bergeron C; Mengelbier LH; Gisselsson D; Kool M; Tytgat GA; van den Heuvel-Eibrink MM; Graf N; van Tinteren H; Coulomb A; Gessler M; Williams RD; Pritchard-Jones K
J Clin Oncol; 2016 Sep; 34(26):3195-203. PubMed ID: 27432915
[TBL] [Abstract][Full Text] [Related]
9. Rare Tumors in Children: Progress Through Collaboration.
Pappo AS; Furman WL; Schultz KA; Ferrari A; Helman L; Krailo MD
J Clin Oncol; 2015 Sep; 33(27):3047-54. PubMed ID: 26304909
[TBL] [Abstract][Full Text] [Related]
10. Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report.
Dix DB; Fernandez CV; Chi YY; Mullen EA; Geller JI; Gratias EJ; Khanna G; Kalapurakal JA; Perlman EJ; Seibel NL; Ehrlich PF; Malogolowkin M; Anderson J; Gastier-Foster J; Shamberger RC; Kim Y; Grundy PE; Dome JS;
J Clin Oncol; 2019 Oct; 37(30):2769-2777. PubMed ID: 31449468
[TBL] [Abstract][Full Text] [Related]
11. [The treatment of nephroblastoma in Africa].
Moreira C; Diagne-Akonde FB; Diouf ND; Ndiaye S
Arch Pediatr; 2015 May; 22(5 Suppl 1):67-8. PubMed ID: 26112526
[No Abstract] [Full Text] [Related]
12. Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia.
Zwaan CM; Kolb EA; Reinhardt D; Abrahamsson J; Adachi S; Aplenc R; De Bont ES; De Moerloose B; Dworzak M; Gibson BE; Hasle H; Leverger G; Locatelli F; Ragu C; Ribeiro RC; Rizzari C; Rubnitz JE; Smith OP; Sung L; Tomizawa D; van den Heuvel-Eibrink MM; Creutzig U; Kaspers GJ
J Clin Oncol; 2015 Sep; 33(27):2949-62. PubMed ID: 26304895
[TBL] [Abstract][Full Text] [Related]
13. Advances in Risk Classification and Treatment Strategies for Neuroblastoma.
Pinto NR; Applebaum MA; Volchenboum SL; Matthay KK; London WB; Ambros PF; Nakagawara A; Berthold F; Schleiermacher G; Park JR; Valteau-Couanet D; Pearson AD; Cohn SL
J Clin Oncol; 2015 Sep; 33(27):3008-17. PubMed ID: 26304901
[TBL] [Abstract][Full Text] [Related]
14. The evolution of treatment for Wilms tumor.
Green DM
J Pediatr Surg; 2013 Jan; 48(1):14-9. PubMed ID: 23331787
[TBL] [Abstract][Full Text] [Related]
15. Progress Born From a Legacy of Collaboration.
Hudson MM; Meyer WH; Pui CH
J Clin Oncol; 2015 Sep; 33(27):2935-7. PubMed ID: 26304907
[No Abstract] [Full Text] [Related]
16. Oncology seen through the prism of Wilms tumor.
D'Angio GJ
Med Pediatr Oncol; 1985; 13(2):53-8. PubMed ID: 2984528
[No Abstract] [Full Text] [Related]
17. Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology.
Royer-Pokora B; Weirich A; Schumacher V; Uschkereit C; Beier M; Leuschner I; Graf N; Autschbach F; Schneider D; von Harrach M
Cancer; 2008 Sep; 113(5):1080-9. PubMed ID: 18618575
[TBL] [Abstract][Full Text] [Related]
18. Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group.
Gratias EJ; Dome JS; Jennings LJ; Chi YY; Tian J; Anderson J; Grundy P; Mullen EA; Geller JI; Fernandez CV; Perlman EJ
J Clin Oncol; 2016 Sep; 34(26):3189-94. PubMed ID: 27400937
[TBL] [Abstract][Full Text] [Related]
19. Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead.
Minard-Colin V; Brugières L; Reiter A; Cairo MS; Gross TG; Woessmann W; Burkhardt B; Sandlund JT; Williams D; Pillon M; Horibe K; Auperin A; Le Deley MC; Zimmerman M; Perkins SL; Raphael M; Lamant L; Klapper W; Mussolin L; Poirel HA; Macintyre E; Damm-Welk C; Rosolen A; Patte C
J Clin Oncol; 2015 Sep; 33(27):2963-74. PubMed ID: 26304908
[TBL] [Abstract][Full Text] [Related]
20. Profiling Loss of Heterozygosity Patterns in a Cohort of Favorable Histology Nephroblastoma Egyptian Patients: What is Consistent With the Rest of the World.
Fawzy M; Bahanassy A; Samir A; Hafez H
Pediatr Hematol Oncol; 2015; 32(8):548-56. PubMed ID: 26390800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
